Gang Wang et al. suggested that OTUD6B-AS1 expression was downregulated in renal cell carcinoma via the Wnt/β-catenin signaling pathway and low expression of the transcript has been correlated with shorter overall survival than patients with high OTUD6B-AS1 expression [63]. This evidence concerns the gene OTUD6B and hereditary clear cell renal cell carcinoma.